Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-25 @ 2:47 AM
NCT ID:
NCT02785133
Eligibility Criteria:
Inclusion Criteria:
* Voluntarily signed informed consent form
* Ages 18-70
* Completed urine pregnancy examination with negative result
* Self-reported energy level of \>4 on the Epworth sleepiness test
* No breastfeeding for 3 months prior to enrollment
Exclusion Criteria:
* Active infection along potential intravenous catheter sites
* Pacemaker
* Currently taking prescription blood thinning medications (i.e. Warfarin)
* Suffering from a chronic, progressive blood disorder, such as blood cancer (Thalassemia, Lymphoma, Myeloma, etc.)
* Use of anti-inflammatory medications on a chronic basis (i.e. ibuprofen, aspirin, and steroids)
* Suffering from blood clotting disorders (hypercoagulable condition, thrombocytosis, etc.)
* Clinically significant anxiety and/or depression
* Participated in a clinical study in the last 30 days
* Clinical Cardiac Disease
* Active Infection
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02785133
Study Brief:
Protocol Section:
NCT02785133